This document is Page 3 of a legal filing (Case 1:20-cr-00330-AJN, likely United States v. Ghislaine Maxwell) dated October 7, 2020, addressed to Judge Alison J. Nathan. The text outlines legal precedents determining the scope of the 'prosecution team' for discovery purposes (Rule 16 and Brady), arguing that the prosecution is not obligated to produce records from other government agencies (like the SEC or components of the DOJ/FBI) unless a specific 'joint investigation' occurred. It cites various cases (Middendorf, Collins, Stein) to establish the criteria for what constitutes a joint investigation.
This document is a page from a legal filing, specifically a brief or motion, dated April 24, 2020. It argues that the involvement of agents from a government agency in an investigation does not automatically make the entire agency part of the "prosecution team" for discovery purposes. The text cites several legal precedents (Stein, Pelullo, Locascio, Ghailani, and Middendorf) to outline the factors courts use to determine the scope of the prosecution team and its disclosure obligations under Rule 16.
This is page 22 of a legal filing (Document 35) from Case 1:19-cr-00830-AT (United States v. Ghislaine Maxwell), filed on April 24, 2020. The text outlines legal arguments and precedents regarding the Government's obligation (under Rule 16 and Brady) to review and produce records held by other agencies. It cites multiple cases to establish that the prosecution is not required to search other agencies' records (such as the SEC, PCAOB, or FAA) unless a 'joint investigation' was conducted with that specific agency.
This document is page 'iii' of a Table of Authorities from a legal filing dated April 24, 2020, in Case 1:19-cr-00830-AT (which corresponds to USA v. Parnas et al., though released in a DOJ OGR batch). It lists numerous legal precedents (case law citations) primarily from the Second Circuit and Southern District of New York, referencing cases such as U.S. v. Coppa, U.S. v. Ghailani, and others used to support legal arguments in the main brief.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity